Ovid Therapeutics (OVID) Shares Outstanding (Entity) (2016 - 2026)
Ovid Therapeutics (OVID) reported Shares Outstanding (Entity) of 184.76 million for Q2 2026, up 159.8% from 71.11 million a year earlier and up 35.7% from the prior quarter.
Powered by 
Analysis
Ovid Therapeutics (OVID) Shares Outstanding (Entity) (2016 - 2026) Analysis & Trends
For FY2025, Ovid Therapeutics posted Shares Outstanding (Entity) of 73.74 million, up 3.8% from FY2024.
- Shares Outstanding (Entity) has increased for ten consecutive years, with a five-year compound annual growth rate of 2.3% (FY2020 to FY2025).
- By year, Shares Outstanding (Entity) came in at 71.01 million in FY2024 (+0.4%), 70.69 million in FY2023 (+0.3%), 70.47 million in FY2022 (+0.1%) and 70.36 million in FY2021 (+7.0%).
- The Q2 2026 figure ranks as the highest quarterly Shares Outstanding (Entity) in data going back to Q1 2016.
- Year over year, Shares Outstanding (Entity) has now increased in each of the last 37 quarters, with growth averaging 32.1% over the last eight quarters.
- Over the past five years, the year-over-year growth in Shares Outstanding (Entity) ranged from 0.1% (Q1 2023) to 159.8% (Q2 2026).
- Per Business Quant data, the three quarters before Q2 2026 came in at 136.17 million (Q1 2026), 73.74 million (Q4 2025) and 71.15 million (Q3 2025).
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Shares Outstanding (Entity.) (Qtr) |
|---|---|---|---|---|---|
| 1 | Johnson & Johnson | 638.12 Bn | 556.64 Bn | 17.26 Bn | 2.41 Bn |
| 2 | AbbVie | 462.60 Bn | 435.75 Bn | 12.70 Bn | 1.77 Bn |
| 3 | Merck | 358.70 Bn | 313.13 Bn | 12.21 Bn | 2.47 Bn |
| 4 | Novartis Ag | 272.16 Bn | 228.03 Bn | 11.24 Bn | - |
| 5 | Astrazeneca | 250.36 Bn | 223.92 Bn | 12.86 Bn | - |
| 6 | Amgen | 227.87 Bn | 183.27 Bn | 7.24 Bn | 540.60 Mn |
| 7 | Gilead Sciences | 184.97 Bn | 159.08 Bn | 6.22 Bn | 1.24 Bn |
| 8 | Pfizer | 162.61 Bn | 109.56 Bn | 10.94 Bn | 5.70 Bn |
| 9 | Vertex Pharmaceuticals | 132.45 Bn | 104.46 Bn | 2.84 Bn | 253.35 Mn |
| 10 | Ovid Therapeutics | 460.04 Mn | 92.06 Mn | - | 184.76 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | 184.76 Mn |
| Mar 31, 2026 | 136.17 Mn |
| Dec 31, 2025 | 73.74 Mn |
| Sep 30, 2025 | 71.15 Mn |
| Jun 30, 2025 | 71.11 Mn |
| Mar 31, 2025 | 71.11 Mn |
| Dec 31, 2024 | 71.01 Mn |
| Sep 30, 2024 | 71.01 Mn |
| Jun 30, 2024 | 70.97 Mn |
| Mar 31, 2024 | 70.78 Mn |
| Dec 31, 2023 | 70.69 Mn |
| Sep 30, 2023 | 70.68 Mn |
| Jun 30, 2023 | 70.60 Mn |
| Mar 31, 2023 | 70.49 Mn |
| Dec 31, 2022 | 70.47 Mn |
| Sep 30, 2022 | 70.47 Mn |
| Jun 30, 2022 | 70.42 Mn |
| Mar 31, 2022 | 70.42 Mn |
| Dec 31, 2021 | 70.36 Mn |
| Sep 30, 2021 | 68.02 Mn |
API Access
Ovid Therapeutics Shares Outstanding (Entity) API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=OVID&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "shares-outstanding-entity", "ticker": "OVID", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=shares-outstanding-entity&ticker=OVID&period=max&api_key=YOUR_API_KEY");
const data = await res.json();